Catalent to offer GSK-developed compound optimisation platform
Catalent Pharma Solutions is offering Optiform, a GSK developed compound optimisation platform, to researchers for the first time.
Archives for August 10, 2010
Latest deals and developments in the CRO space
Outsourcing-pharma presents a round-up of recent developments in the contract research sector, with news from Quintiles, Bioclinica and Cyprotex.
Elan halts EDT sale, again; AD drug into Ph III
Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”
Merck to buy back Riverside plant for key API supply
US drugmaker Merck & Co has announced plans to reacquire a Pennsylvania manufacturing plant to guarantee supply of key active pharmaceutical ingredient (API).
Medicago to build 90,000 sq ft vaccine plant in RTP
Medicago is to build a 90,000 sq ft cGMP vaccine facility in RTP, North Carolina, US using a $21m (€16.1m) grant from the US Department of Defense.